Loading...

Milestone Pharmaceuticals ($MIST)

Stock Image

MIST Overview

Milestone Pharmaceuticals, a biopharmaceutical company, develops and commercializes etripamil for the treatment of cardiovascular indications.It is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for the treatment of atrial fibrillation, angina, and other cardiovascular indications.The company was founded in 2003 and is headquartered in Montréal, Canada. (From: StockAnalysis.com)

MORE ABOUT Milestone Pharmaceuticals

Stay up to date with the best of Bullish each week.

BULLISH WEEKLY

Stay up to date with the best of Bullish each week.